VivoSim Labs VIVS
NASDAQ VIVS
$0.26 0.00 (-0.27%)
As of: Sep 17, 2026 · 3:59 PM EDT

VivoSim Labs (VIVS) Shares Outstanding (2011 - 2026)

VivoSim Labs (VIVS) posted Shares Outstanding (Entity) of $5.2 million for Q2 2026, up 81.01% on a QoQ basis from $2.9 million in Q1 2026, and up 101.53% year-over-year from $2.6 million in Q2 2025.

Analysis

VivoSim Labs (VIVS) Shares Outstanding (2011 - 2026) Analysis & Trends

VivoSim Labs has reported Shares Outstanding (Entity) for 16 years, with the latest figure at $5.2 million in Q2 2026.

  • On a quarterly basis, Shares Outstanding (Entity) rose 101.53% year-over-year to $5.2 million in Q2 2026; TTM through Jun 2026 was $5.2 million, a 101.53% increase from a year earlier, with the FY2026 full-year figure at $2.9 million, up 97.77% from the prior year.
  • Shares Outstanding (Entity) was $5.2 million for Q2 2026 at VivoSim Labs, up from $2.9 million in the prior quarter.
  • The five-year high for Shares Outstanding (Entity) was $5.2 million in Q2 2026, with the low at $725857.0 in Q1 2022.
  • Average Shares Outstanding (Entity) over 5 years is $1.6 million, with a median of $1.0 million recorded in 2024.
  • The sharpest annual moves came in 2023 and 2025: Shares Outstanding (Entity) advanced 0.07% in 2023, then surged 117.06% in 2025.
  • Over 5 years, Shares Outstanding (Entity) stood at $726187.0 in 2022, then advanced by 12.9% to $819863.0 in 2023, then surged by 74.14% to $1.4 million in 2024, then jumped by 82.67% to $2.6 million in 2025, then jumped by 100.9% to $5.2 million in 2026.
  • The last three Shares Outstanding (Entity) figures came in at $5.2 million (Q2 2026), $2.9 million (Q1 2026), and $2.6 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn 166.10 Mn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn 28.17 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn 78.42 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn 48.02 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn 94.80 Mn
6 Evotec SE 574.75 Mn 148.87 Mn - 355.16 Mn
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn 62.09 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn 13.90 Mn
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn 46.38 Mn
10 VivoSim Labs 1.37 Mn 1.37 Mn - 5.24 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.24 Mn
Mar 31, 2026 2.59 Mn
Dec 31, 2025 2.61 Mn
Sep 30, 2025 2.60 Mn
Jun 30, 2025 2.50 Mn
Mar 31, 2025 1.46 Mn
Dec 31, 2024 1.50 Mn
Sep 30, 2024 1.50 Mn
Jun 30, 2024 1.22 Mn
Mar 31, 2024 762,046.00
Dec 31, 2023 759,591.00
Sep 30, 2023 726,513.00
Jun 30, 2023 726,407.00
Mar 31, 2023 726,057.00
Dec 31, 2022 726,106.00
Sep 30, 2022 725,995.00
Jun 30, 2022 725,885.00
Mar 31, 2022 725,271.00
Dec 31, 2021 725,430.00
Sep 30, 2021 725,415.00